Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias - Trial NCT03204981
Access comprehensive clinical trial information for NCT03204981 through Pure Global AI's free database. This phase not specified trial is sponsored by Vivek Reddy and is currently Completed. The study focuses on Ventricular Arrythmia. Target enrollment is 52 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Vivek Reddy
Icahn School of Medicine at Mount Sinai
Timeline & Enrollment
N/A
Oct 17, 2017
Apr 20, 2021
Primary Outcome
Number of Participants Who Had Freedom From Ventricular Arrhythmia at 6 Months
Summary
This study will examine the safety and efficacy of intramural needle ablation (INA) in the
 treatment of intramural ventricular arrhythmias in patients for whom standard RF ablation has
 been unsuccessful. The clinical team hypothesize that the increased current density and
 improved rates of transmural lesion creation seen with intramural needle ablation will lead
 to successful arrhythmia termination with minimal or no increased risk of complication.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03204981
Device Trial